Our company’s roots go back to 2008, when our founders began designing and building the basic Robotic Capsule Endoscopy technology in Silicon Valley.

THE NAVICAM STOMACH SYSTEM

In May of 2020, FDA granted AnX Robotica the De Novo request for the NaviCam Stomach System, the world’s first commercialized robotic control platform for stomach visualization. The NaviCam Stomach System utilizes advanced robotic technologies combined with innovative and intelligent software to give medical practitioners external robotic control of capsules inside the human body.

AnX Robotica’s NaviCam Stomach System has achieved a medical milestone by enabling the ability to perform a stomach examination with a minimally invasive, patient-friendly procedure while giving the physician complete control. By simply swallowing a pill-sized capsule, patients can undergo a thorough stomach examination without the need for sedation.

THE NAVICAM PLATFORM – A GLIMPSE INTO THE FUTURE

With the innovative NaviCam Platform, AnX Robotica has developed a new way for a thorough visualization of the stomach. In addition to the NaviCam Stomach System, AnX Robotica also markets IntraMarx and IntraMarX 3D Radiopaque Markers for colonic transit testing in the US.

Outside the US, AnX Robotica markets the NaviCam SB System for Small Bowel and NaviCam UGI for upper GI studies. Our ProScan™ for small bowel endoscopy was recognized in Gastroenterology as a “New Era for Diagnosis of Small Bowel Disease”, while other technologies including the NaviCam Colon and VibraBot™, a capsule for the treatment of constipation, are in development.

AnX Robotica news

Contact supplier